Alendronate sodium is a drug which belongs to a medicine group called bisphosphonates. It contains alendronate monosodium salt and minimal amounts of starch, mannitol, magnesium stearate, microcrystalline cellulose, and sodium starch glycoate.
It was introduced in the market to treat osteoporosis in men and women. It goes by the name of Fosamax. It is also used to treat Paget’s disease and reduce bone mass. Side-effects of taking this drug include heartburn, pain in legs & chest, and numbness.
Browse the Full Alendronate Sodium Industry – Global Scenario, Industry Outlook, Share, and Industry analysis, Size, Trends and Forecast, 2015 To 2020 Report at – http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report
The alendronate sodium market is projected to experience a significant growth rate during the forecast period (2015-2020). The high growth rate can be ascribed to the compound being a vital ingredient in many medicines. The advent of other lifestyle-related diseases such as insomnia and rheumatoid arthritis will be a prime factor influencing market growth. Toxic nature of the drug can pose a challenge to industry growth.
Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Product types include freeze-dried powder and injections. Hospitals, clinics, and others constitute as major market applications. Hospitals will record a decent demand for the drug in the forecast period. It has been recommended by doctors to treat osteoporosis and reduce bone resorption. The drug combined with nanoparticles is expected to improve bone regeneration. This could prove to be beneficial to the alendronate sodium industry.
Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report/request-sample
Regions covered under the market are USA, UK, Japan, Australia, Germany, Switzerland, Singapore, Canada, and Italy. USA will lose market shares due to lethal side-effects of the drug causing discontent among patients. UK, Switzerland, and Germany will experience sluggish growth due to the tough market regulations.
Prominent manufacturers in the global alendronate sodium market are Xi’an Miracle Biotechnology Co., Ltd., Sigma-Aldrich, Cayman Chemical Company, and Merck Sharp & Dohme (MSD) Pty Ltd. The global market is competitive in nature. New participants can gain an entry to the market as drug patents of major pharmaceutical companies have reached their expiry dates.
Related Reports by Radiant Insights:
• Trimethylolpropane Trivinyl Ether (TMPTVE) (CAS 57758-90-4) Industry
• 1,2,3,4-Tetrafluorobenzene (CAS 551-62-2) Industry
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their Market research and business intelligence requirements. It assist and facilitate organizations and individuals procure Market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro Markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.radiantinsights.com/research/global-and-chinese-alendronate-sodium-industry-2015-market-research-report